T1	NC 0 5	Mujer
#1	Norm T1	mujer NCFS000
T2	SP 6 8	de
#2	Norm T2	de SPS00
T3	Z 9 11	60
#3	Norm T3	60 Z
T4	NC 12 16	años
#4	Norm T4	año NCMP000
T5	VM 17 30	diagnosticada
#5	Norm T5	diagnosticar VMP00SF
T6	SP 31 33	en
#6	Norm T6	en SPS00
T7	NC 34 39	enero
#7	Norm T7	enero NCMS000
T8	SP 40 42	de
#8	Norm T8	de SPS00
T9	Z 43 47	2010
#9	Norm T9	2010 Z
T10	SP 48 50	de
#10	Norm T10	de SPS00
T11	NC 51 54	LMC
#11	Norm T11	LMC NC00000
T12	NP 55 62	BCR-ABL
#12	Norm T12	bcr-abl NP00000
T13	AQ 63 71	positivo
#13	Norm T13	positivo AQ0MS0
T14	Fp 71 72	.
#14	Norm T14	. Fp
T15	SP 73 78	Desde
#15	Norm T15	desde SPS00
T16	DA 79 81	el
#16	Norm T16	el DA0MS0
T17	NC 82 93	diagnóstico
#17	Norm T17	diagnóstico NCMS000
T18	SP 94 99	hasta
#18	Norm T18	hasta SPS00
T19	NC 100 105	abril
#19	Norm T19	abril NCMS000
T20	SP 106 108	de
#20	Norm T20	de SPS00
T21	Z 109 113	2011
#21	Norm T21	2011 Z
T22	VM 114 121	recibió
#22	Norm T22	recibir VMIS3S0
T23	NC 122 133	tratamiento
#23	Norm T23	tratamiento NCMS000
T24	SP 134 137	con
#24	Norm T24	con SPS00
T25	NC 138 146	imatinib
#25	Norm T25	imatinib NCMS000
T26	Z 147 150	400
#26	Norm T26	400 Z
T27	NC 150 152	mg
#27	Norm T27	mg NC00000
T28	Fh 152 153	/
#28	Norm T28	/ Fh
T29	NC 153 156	día
#29	Norm T29	día NCMS000
T30	SP 157 160	con
#30	Norm T30	con SPS00
T31	AQ 161 170	aceptable
#31	Norm T31	aceptable AQ0CS0
T32	NC 171 181	tolerancia
#32	Norm T32	tolerancia NCFS000
T33	Fpa 182 183	(
#33	Norm T33	( Fpa
T34	NC 183 191	síntomas
#34	Norm T34	síntoma NCMP000
T35	VM 192 201	moderados
#35	Norm T35	moderar VMP00PM
T36	SP 202 204	de
#36	Norm T36	de SPS00
T37	NC 205 214	cansancio
#37	Norm T37	cansancio NCMS000
T38	Fc 214 215	,
#38	Norm T38	, Fc
T39	NC 216 221	dolor
#39	Norm T39	dolor NCMS000
T40	Fc 221 222	,
#40	Norm T40	, Fc
T41	NC 223 231	quemazón
#41	Norm T41	quemazón NCFS000
T42	CC 232 233	e
#42	Norm T42	y CC
T43	NC 234 243	hinchazón
#43	Norm T43	hinchazón NCFS000
T44	SP 244 246	en
#44	Norm T44	en SPS00
T45	NC 247 254	piernas
#45	Norm T45	pierna NCFP000
T46	Fc 254 255	,
#46	Norm T46	, Fc
T47	NC 256 262	edemas
#47	Norm T47	edema NCMP000
T48	SP 263 265	en
#48	Norm T48	en SPS00
T49	NC 266 274	párpados
#49	Norm T49	párpado NCMP000
T50	CC 275 276	y
#50	Norm T50	y CC
T51	NC 277 286	aparición
#51	Norm T51	aparición NCFS000
T52	SP 287 289	de
#52	Norm T52	de SPS00
T53	NC 290 298	lesiones
#53	Norm T53	lesión NCFP000
T54	AQ 299 311	blanquecinas
#54	Norm T54	blanquecino AQ0FP0
T55	SP 312 314	en
#55	Norm T55	en SPS00
T56	NC 315 320	lecho
#56	Norm T56	lecho NCMS000
T57	AQ 321 328	ungueal
#57	Norm T57	ungueal AQ0CS0
T58	Fpt 328 329	)
#58	Norm T58	) Fpt
T59	CC 330 331	y
#59	Norm T59	y CC
T60	NC 332 341	respuesta
#60	Norm T60	respuesta NCFS000
T61	AQ 342 354	hematológica
#61	Norm T61	hematológico AQ0FS0
T62	RG 355 358	muy
#62	Norm T62	muy RG
T63	AQ 359 365	rápida
#63	Norm T63	rápido AQ0FS0
T64	VM 366 378	observándose
#64	Norm T64	observar+se VMG0000+PP3CN000
T65	NC 379 392	normalización
#65	Norm T65	normalización NCFS000
T66	SP 393 396	del
#66	Norm T66	de+el SPS00+DA0MS0
T67	NC 397 406	hemograma
#67	Norm T67	hemograma NCMS000
T68	SP 407 409	en
#68	Norm T68	en SPS00
T69	DI 410 413	una
#69	Norm T69	uno DI0FS0
T70	NC 414 420	semana
#70	Norm T70	semana NCFS000
T71	Fp 420 421	.
#71	Norm T71	. Fp
T72	SP 422 424	En
#72	Norm T72	en SPS00
T73	NC 425 430	abril
#73	Norm T73	abril NCMS000
T74	SP 431 433	de
#74	Norm T74	de SPS00
T75	Z 434 438	2011
#75	Norm T75	2011 Z
T76	Fc 438 439	,
#76	Norm T76	, Fc
T77	SP 440 444	ante
#77	Norm T77	ante SPS00
T78	DA 445 447	la
#78	Norm T78	el DA0FS0
T79	NC 448 458	progresión
#79	Norm T79	progresión NCFS000
T80	SP 459 461	de
#80	Norm T80	de SPS00
T81	DA 462 464	la
#81	Norm T81	el DA0FS0
T82	NC 465 470	señal
#82	Norm T82	señal NCFS000
T83	AQ 471 480	molecular
#83	Norm T83	molecular AQ0CS0
T84	CC 481 482	y
#84	Norm T84	y CC
T85	DA 483 485	la
#85	Norm T85	el DA0FS0
T86	NC 486 497	adquisición
#86	Norm T86	adquisición NCFS000
T87	SP 498 500	de
#87	Norm T87	de SPS00
T88	DA 501 503	la
#88	Norm T88	el DA0FS0
T89	NC 504 512	mutación
#89	Norm T89	mutación NCFS000
T90	NC 513 518	Y253F
#90	Norm T90	Y253F NC00000
T91	SP 519 521	en
#91	Norm T91	en SPS00
T92	NC 522 528	sangre
#92	Norm T92	sangre NCFS000
T93	AQ 529 539	periférica
#93	Norm T93	periférico AQ0FS0
T94	Fpa 540 541	(
#94	Norm T94	( Fpa
T95	NC 541 543	SP
#95	Norm T95	SP NC00000
T96	Fpt 543 544	)
#96	Norm T96	) Fpt
T97	CC 545 546	y
#97	Norm T97	y CC
T98	NC 547 553	médula
#98	Norm T98	médula NCFS000
T99	AQ 554 558	ósea
#99	Norm T99	óseo AQ0FS0
T100	Fpa 559 560	(
#100	Norm T100	( Fpa
T101	NC 560 562	MO
#101	Norm T101	MO NC00000
T102	Fpt 562 563	)
#102	Norm T102	) Fpt
T103	Fc 563 564	,
#103	Norm T103	, Fc
T104	P0 565 567	se
#104	Norm T104	se P00CN000
T105	VM 568 577	sustituyó
#105	Norm T105	sustituir VMIS3S0
T106	NC 578 586	imatinib
#106	Norm T106	imatinib NCMS000
T107	SP 587 590	por
#107	Norm T107	por SPS00
T108	NC 591 600	dasatinib
#108	Norm T108	dasatinib NC00000
T109	Z 601 604	100
#109	Norm T109	100 Z
T110	NC 604 606	mg
#110	Norm T110	mg NC00000
T111	Fh 606 607	/
#111	Norm T111	/ Fh
T112	NC 607 610	día
#112	Norm T112	día NCMS000
T113	Fp 610 611	.
#113	Norm T113	. Fp
T114	DA 612 614	La
#114	Norm T114	el DA0FS0
T115	NC 615 623	mutación
#115	Norm T115	mutación NCFS000
T116	NC 624 629	Y253F
#116	Norm T116	Y253F NC00000
T117	VM 630 638	confiere
#117	Norm T117	conferir VMIP3S0
T118	NC 639 650	resistencia
#118	Norm T118	resistencia NCFS000
T119	SP 651 652	a
#119	Norm T119	a SPS00
T120	NC 653 661	imatinib
#120	Norm T120	imatinib NCMS000
T121	Fc 661 662	,
#121	Norm T121	, Fc
T122	NC 663 675	sensibilidad
#122	Norm T122	sensibilidad NCFS000
T123	AQ 676 686	intermedia
#123	Norm T123	intermedio AQ0FS0
T124	SP 687 688	a
#124	Norm T124	a SPS00
T125	NC 689 698	nilotinib
#125	Norm T125	nilotinib NC00000
T126	CC 699 700	y
#126	Norm T126	y CC
T127	NC 701 713	sensibilidad
#127	Norm T127	sensibilidad NCFS000
T128	SP 714 715	a
#128	Norm T128	a SPS00
T129	NC 716 725	dasatinib
#129	Norm T129	dasatinib NC00000
T130	Fp 725 726	.
#130	Norm T130	. Fp
T131	DA 727 729	La
#131	Norm T131	el DA0FS0
T132	NC 730 738	paciente
#132	Norm T132	paciente NCCS000
T133	VM 739 747	presentó
#133	Norm T133	presentar VMIS3S0
T134	AQ 748 753	buena
#134	Norm T134	bueno AQ0FS0
T135	NC 754 764	tolerancia
#135	Norm T135	tolerancia NCFS000
T136	AQ 765 772	clínica
#136	Norm T136	clínico AQ0FS0
T137	SP 773 780	durante
#137	Norm T137	durante SPS00
T138	DA 781 783	el
#138	Norm T138	el DA0MS0
T139	NC 784 795	tratamiento
#139	Norm T139	tratamiento NCMS000
T140	SP 796 799	con
#140	Norm T140	con SPS00
T141	NC 800 809	dasatinib
#141	Norm T141	dasatinib NC00000
T142	Fc 809 810	,
#142	Norm T142	, Fc
T143	SP 811 818	excepto
#143	Norm T143	excepto SPS00
T144	SP 819 822	por
#144	Norm T144	por SPS00
T145	DA 823 825	la
#145	Norm T145	el DA0FS0
T146	NC 826 835	aparición
#146	Norm T146	aparición NCFS000
T147	SP 836 838	de
#147	Norm T147	de SPS00
T148	DI 839 841	un
#148	Norm T148	uno DI0MS0
T149	NC 842 848	cuadro
#149	Norm T149	cuadro NCMS000
T150	SP 849 851	de
#150	Norm T150	de SPS00
T151	NC 852 855	tos
#151	Norm T151	tos NCFS000
T152	AQ 856 867	persistente
#152	Norm T152	persistente AQ0CS0
T153	CC 868 869	y
#153	Norm T153	y CC
T154	NC 870 877	astenia
#154	Norm T154	astenia NCFS000
T155	Fc 877 878	,
#155	Norm T155	, Fc
T156	VM 879 889	alcanzando
#156	Norm T156	alcanzar VMG0000
T157	NC 890 899	respuesta
#157	Norm T157	respuesta NCFS000
T158	AQ 900 909	molecular
#158	Norm T158	molecular AQ0CS0
T159	AQ 910 915	mayor
#159	Norm T159	mayor AQ0CS0
T160	Fp 915 916	.
#160	Norm T160	. Fp
T161	SP 917 924	Durante
#161	Norm T161	durante SPS00
T162	DA 925 927	el
#162	Norm T162	el DA0MS0
T163	NC 928 939	tratamiento
#163	Norm T163	tratamiento NCMS000
T164	SP 940 943	con
#164	Norm T164	con SPS00
T165	NC 944 953	dasatinib
#165	Norm T165	dasatinib NC00000
T166	Fc 953 954	,
#166	Norm T166	, Fc
T167	DA 955 957	la
#167	Norm T167	el DA0FS0
T168	NC 958 966	paciente
#168	Norm T168	paciente NCCS000
T169	VM 967 977	desarrolló
#169	Norm T169	desarrollar VMIS3S0
T170	NC 978 990	pancitopenia
#170	Norm T170	pancitopenia NCFS000
T171	SP 991 994	con
#171	Norm T171	con SPS00
T172	NC 995 1007	infiltración
#172	Norm T172	infiltración NCFS000
T173	AQ 1008 1016	blástica
#173	Norm T173	blástico AQ0FS0
T174	SP 1017 1019	de
#174	Norm T174	de SPS00
T175	DA 1020 1022	la
#175	Norm T175	el DA0FS0
T176	NC 1023 1025	MO
#176	Norm T176	MO NC00000
T177	Fc 1025 1026	,
#177	Norm T177	, Fc
T178	VM 1027 1039	realizándose
#178	Norm T178	realizar+se VMG0000+PP3CN000
T179	DA 1040 1042	el
#179	Norm T179	el DA0MS0
T180	NC 1043 1054	diagnóstico
#180	Norm T180	diagnóstico NCMS000
T181	SP 1055 1057	de
#181	Norm T181	de SPS00
T182	NC 1058 1064	crisis
#182	Norm T182	crisis NCFN000
T183	AQ 1065 1073	blástica
#183	Norm T183	blástico AQ0FS0
T184	AQ 1074 1082	linfoide
#184	Norm T184	linfoide AQ0CS0
T185	CC 1083 1084	y
#185	Norm T185	y CC
T186	VM 1085 1097	detectándose
#186	Norm T186	detectar+se VMG0000+PP3CN000
T187	DA 1098 1100	la
#187	Norm T187	el DA0FS0
T188	NC 1101 1109	mutación
#188	Norm T188	mutación NCFS000
T189	NC 1110 1115	T315I
#189	Norm T189	T315I NC00000
T190	SP 1116 1118	en
#190	Norm T190	en SPS00
T191	DA 1119 1121	el
#191	Norm T191	el DA0MS0
T192	NC 1122 1129	dominio
#192	Norm T192	dominio NCMS000
T193	NC 1130 1133	ABL
#193	Norm T193	ABL NC00000
T194	NC 1134 1140	cinasa
#194	Norm T194	cinasa NCFS000
T195	Fp 1140 1141	.
#195	Norm T195	. Fp
T196	DI 1142 1145	Una
#196	Norm T196	uno DI0FS0
T197	NC 1146 1149	vez
#197	Norm T197	vez NCFS000
T198	VM 1150 1159	alcanzada
#198	Norm T198	alcanzar VMP00SF
T199	NC 1160 1168	remisión
#199	Norm T199	remisión NCFS000
T200	AQ 1169 1180	morfológica
#200	Norm T200	morfológico AQ0FS0
T201	SP 1181 1184	del
#201	Norm T201	de+el SPS00+DA0MS0
T202	NC 1185 1191	cuadro
#202	Norm T202	cuadro NCMS000
T203	SP 1192 1194	de
#203	Norm T203	de SPS00
T204	NC 1195 1201	crisis
#204	Norm T204	crisis NCFN000
T205	AQ 1202 1210	blástica
#205	Norm T205	blástico AQ0FS0
T206	SP 1211 1215	tras
#206	Norm T206	tras SPS00
T207	DA 1216 1218	la
#207	Norm T207	el DA0FS0
T208	NC 1219 1233	administración
#208	Norm T208	administración NCFS000
T209	SP 1234 1236	de
#209	Norm T209	de SPS00
T210	NC 1237 1250	quimioterapia
#210	Norm T210	quimioterapia NCFS000
T211	SP 1251 1253	de
#211	Norm T211	de SPS00
T212	NC 1254 1263	inducción
#212	Norm T212	inducción NCFS000
T213	SP 1264 1267	con
#213	Norm T213	con SPS00
T214	NC 1268 1279	vincristina
#214	Norm T214	vincristina NCFS000
T215	Fc 1279 1280	,
#215	Norm T215	, Fc
T216	NC 1281 1295	daunorrubicina
#216	Norm T216	daunorrubicina NC00000
T217	Fc 1295 1296	,
#217	Norm T217	, Fc
T218	NC 1297 1307	esteroides
#218	Norm T218	esteroide NCMP000
T219	CC 1308 1309	y
#219	Norm T219	y CC
T220	NC 1310 1320	profilaxis
#220	Norm T220	profilaxis NCFN000
T221	AQ 1321 1331	intratecal
#221	Norm T221	intratecal AQ0CS0
T222	CC 1332 1333	y
#222	Norm T222	y CC
T223	VM 1334 1338	dada
#223	Norm T223	dar VMP00SF
T224	DA 1339 1341	la
#224	Norm T224	el DA0FS0
T225	NC 1342 1352	exposición
#225	Norm T225	exposición NCFS000
T226	AQ 1353 1359	previa
#226	Norm T226	previo AQ0FS0
T227	SP 1360 1361	a
#227	Norm T227	a SPS00
T228	NC 1362 1370	imatinib
#228	Norm T228	imatinib NCMS000
T229	CC 1371 1372	y
#229	Norm T229	y CC
T230	NC 1373 1382	dasatinib
#230	Norm T230	dasatinib NC00000
T231	Fc 1382 1383	,
#231	Norm T231	, Fc
T232	DA 1384 1386	el
#232	Norm T232	el DA0MS0
T233	NP 1387 1410	Servicio de Hematología
#233	Norm T233	servicio_de_hematología NP00000
T234	VM 1411 1417	decide
#234	Norm T234	decidir VMIP3S0
T235	VM 1418 1425	iniciar
#235	Norm T235	iniciar VMN0000
T236	NC 1426 1437	tratamiento
#236	Norm T236	tratamiento NCMS000
T237	SP 1438 1441	con
#237	Norm T237	con SPS00
T238	NC 1442 1451	ponatinib
#238	Norm T238	ponatinib NC00000
T239	SP 1452 1454	en
#239	Norm T239	en SPS00
T240	NC 1455 1465	septiembre
#240	Norm T240	septiembre NCMS000
T241	SP 1466 1468	de
#241	Norm T241	de SPS00
T242	Z 1469 1473	2012
#242	Norm T242	2012 Z
T243	Fp 1473 1474	.
#243	Norm T243	. Fp
T244	RG 1475 1487	Inicialmente
#244	Norm T244	inicialmente RG
T245	DA 1488 1490	la
#245	Norm T245	el DA0FS0
T246	NC 1491 1496	dosis
#246	Norm T246	dosis NCFN000
T247	VM 1497 1509	administrada
#247	Norm T247	administrar VMP00SF
T248	VS 1510 1513	fue
#248	Norm T248	ser VSIS3S0
T249	SP 1514 1516	de
#249	Norm T249	de SPS00
T250	Z 1517 1519	45
#250	Norm T250	45 Z
T251	NC 1519 1521	mg
#251	Norm T251	mg NC00000
T252	NC 1522 1525	día
#252	Norm T252	día NCMS000
T253	Fc 1525 1526	,
#253	Norm T253	, Fc
T254	PR 1527 1530	que
#254	Norm T254	que PR0CN000
T255	VM 1531 1535	tuvo
#255	Norm T255	tener VMIS3S0
T256	CS 1536 1539	que
#256	Norm T256	que CS
T257	VS 1540 1543	ser
#257	Norm T257	ser VSN0000
T258	VM 1544 1554	disminuida
#258	Norm T258	disminuir VMP00SF
T259	SP 1555 1556	a
#259	Norm T259	a SPS00
T260	Z 1557 1559	30
#260	Norm T260	30 Z
T261	NC 1559 1561	mg
#261	Norm T261	mg NC00000
T262	SP 1562 1564	al
#262	Norm T262	a+el SPS00+DA0MS0
T263	NC 1565 1568	día
#263	Norm T263	día NCMS000
T264	SP 1569 1572	por
#264	Norm T264	por SPS00
T265	NC 1573 1585	intolerancia
#265	Norm T265	intolerancia NCFS000
T266	AQ 1586 1593	clínica
#266	Norm T266	clínico AQ0FS0
T267	Fc 1593 1594	,
#267	Norm T267	, Fc
T268	RG 1595 1611	fundamentalmente
#268	Norm T268	fundamentalmente RG
T269	NC 1612 1617	dolor
#269	Norm T269	dolor NCMS000
T270	AQ 1618 1631	osteomuscular
#270	Norm T270	osteomuscular AQ0CS0
T271	Fc 1631 1632	,
#271	Norm T271	, Fc
T272	NC 1633 1640	astenia
#272	Norm T272	astenia NCFS000
T273	CC 1641 1642	y
#273	Norm T273	y CC
T274	NC 1643 1652	elevación
#274	Norm T274	elevación NCFS000
T275	SP 1653 1655	de
#275	Norm T275	de SPS00
T276	NC 1656 1663	tensión
#276	Norm T276	tensión NCFS000
T277	AQ 1664 1672	arterial
#277	Norm T277	arterial AQ0CS0
T278	Fc 1672 1673	,
#278	Norm T278	, Fc
T279	PR 1674 1677	que
#279	Norm T279	que PR0CN000
T280	VM 1678 1684	obligó
#280	Norm T280	obligar VMIS3S0
T281	SP 1685 1687	al
#281	Norm T281	a+el SPS00+DA0MS0
T282	NC 1688 1694	ajuste
#282	Norm T282	ajuste NCMS000
T283	SP 1695 1698	del
#283	Norm T283	de+el SPS00+DA0MS0
T284	NC 1699 1710	tratamiento
#284	Norm T284	tratamiento NCMS000
T285	AQ 1711 1727	antihipertensivo
#285	Norm T285	antihipertensivo AQ0MS0
T286	Fp 1727 1728	.
#286	Norm T286	. Fp
T287	RG 1729 1740	Actualmente
#287	Norm T287	actualmente RG
T288	Fc 1740 1741	,
#288	Norm T288	, Fc
T289	DA 1742 1744	la
#289	Norm T289	el DA0FS0
T290	NC 1745 1753	paciente
#290	Norm T290	paciente NCCS000
T291	VM 1754 1762	mantiene
#291	Norm T291	mantener VMIP3S0
T292	DA 1763 1765	la
#292	Norm T292	el DA0FS0
T293	NC 1766 1775	respuesta
#293	Norm T293	respuesta NCFS000
T294	AQ 1776 1788	hematológica
#294	Norm T294	hematológico AQ0FS0
T295	CC 1789 1790	y
#295	Norm T295	y CC
T296	AQ 1791 1800	molecular
#296	Norm T296	molecular AQ0CS0
T297	AQ 1801 1809	completa
#297	Norm T297	completo AQ0FS0
T298	SP 1810 1813	con
#298	Norm T298	con SPS00
T299	AQ 1814 1823	aceptable
#299	Norm T299	aceptable AQ0CS0
T300	NC 1824 1834	tolerancia
#300	Norm T300	tolerancia NCFS000
T301	Fp 1834 1835	.
#301	Norm T301	. Fp
T302	VA 1836 1838	Ha
#302	Norm T302	haber VAIP3S0
T303	VS 1839 1843	sido
#303	Norm T303	ser VSP00SM
T304	VM 1844 1852	valorada
#304	Norm T304	valorar VMP00SF
T305	RG 1853 1866	recientemente
#305	Norm T305	recientemente RG
T306	SP 1867 1869	en
#306	Norm T306	en SPS00
T307	DA 1870 1872	la
#307	Norm T307	el DA0FS0
T308	NC 1873 1881	consulta
#308	Norm T308	consulta NCFS000
T309	SP 1882 1884	de
#309	Norm T309	de SPS00
T310	NC 1885 1898	pretrasplante
#310	Norm T310	pretrasplante NCMS000
T311	SP 1899 1902	del
#311	Norm T311	de+el SPS00+DA0MS0
T312	NP 1903 1926	Servicio de Hematología
#312	Norm T312	servicio_de_hematología NP00000
T313	SP 1927 1931	para
#313	Norm T313	para SPS00
T314	NC 1932 1943	posibilidad
#314	Norm T314	posibilidad NCFS000
T315	SP 1944 1946	de
#315	Norm T315	de SPS00
T316	NC 1947 1960	consolidación
#316	Norm T316	consolidación NCFS000
T317	SP 1961 1964	con
#317	Norm T317	con SPS00
T318	NC 1965 1968	TPH
#318	Norm T318	TPH NC00000
T319	AQ 1969 1978	alogénico
#319	Norm T319	alogénico AQ0MS0
T320	SP 1979 1981	de
#320	Norm T320	de SPS00
T321	NC 1982 1989	donante
#321	Norm T321	donante NCCS000
T322	RN 1990 1992	no
#322	Norm T322	no RN
T323	VM 1993 2004	emparentado
#323	Norm T323	emparentar VMP00SM
T324	Fc 2004 2005	,
#324	Norm T324	, Fc
T325	RG 2006 2008	ya
#325	Norm T325	ya RG
T326	CS 2009 2012	que
#326	Norm T326	que CS
T327	RN 2013 2015	no
#327	Norm T327	no RN
T328	VM 2016 2023	dispone
#328	Norm T328	disponer VMIP3S0
T329	SP 2024 2026	de
#329	Norm T329	de SPS00
T330	NC 2027 2034	hermano
#330	Norm T330	hermano NCMS000
T331	NC 2035 2038	HLA
#331	Norm T331	HLA NC00000
T332	AQ 2039 2049	compatible
#332	Norm T332	compatible AQ0CS0
T333	Fp 2049 2050	.
#333	Norm T333	. Fp
